Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jennifer Gunter
Bcl‐2 Inhibitors Enhance FGFR Inhibitor‐induced Mitochondrial‐dependent Cell Death in FGFR 2 Mutant Endometrial Cancer
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Related publications
PI3K Inhibitors Synergize With FGFR Inhibitors to Enhance Antitumor Responses in FGFR2 Mutant Endometrial Cancers
Molecular Cancer Therapeutics
Cancer Research
Oncology
Mitochondrial Signaling in Cell Death via the BCL-2 Family
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Rogaratinib: A Potent and Selective Pan-FGFR Inhibitor With Broad Antitumor Activity in FGFR-overexpressing Preclinical Cancer Models
International Journal of Cancer
Cancer Research
Oncology
Targeting FGFR Signaling in Cancer
Clinical Cancer Research
Cancer Research
Oncology
BCL-2 Prevents Caspase-Independent Cell Death
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Small Peptides Against the Mutant SOD1/Bcl-2 Toxic Mitochondrial Complex Restore Mitochondrial Function and Cell Viability in Mutant SOD1-Mediated ALS
Journal of Neuroscience
Neuroscience
BCL-2-Associated Athanogene 5 (BAG5) Regulates Parkin-Dependent Mitophagy and Cell Death
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Inhibition of Glutathione Synthesis Overcomes BCL-2-Mediated Topoisomerase Inhibitor Resistance and Induces Nonapoptotic Cell Death via Mitochondrial-Independent Pathway
Cancer Research
Cancer Research
Oncology
Discovery of Potent Irreversible Pan-Fibroblast Growth Factor Receptor (FGFR) Inhibitors
